PT  - JOURNAL ARTICLE
AU  - Tuğba Akman Yıldız
AU  - Emek Köse
AU  - Necibe Tuncer
TI  - Assessment of Vaccination and Underreporting on COVID-19 Infections in Turkey Based On Effective Reproduction Number
AID  - 10.1101/2021.02.04.21251176
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.04.21251176
4099  - http://medrxiv.org/content/early/2021/04/21/2021.02.04.21251176.short
4100  - http://medrxiv.org/content/early/2021/04/21/2021.02.04.21251176.full
AB  - In this paper, we introduce a SEIR type COVID-19 model where the infected class is further divided into subclasses with individuals in intensive care (ICUs) and ventilation units. The model is validated with the symptomatic COVID-19 cases, deaths, and the number of patients in ICUs and ventilation units as reported by Republic of Turkey, Ministry of Health for the period March 11, 2020 through May 30, 2020 when the nationwide lockdown is in order. COVID-19 interventions in Turkey are incorporated into the model to detect the future trend of the outbreak accurately. We tested the effect of underreporting and we found that the peaks of the disease differ significantly depending on the rate of underreporting, however, the timing of the peaks remains constant.The lockdown is lifted on June 1, and the model is modified to include a time dependent transmission rate which is linked to the effective reproduction number ℛt through basic reproduction number ℛ0. The modified model captures the changing dynamics and peaks of the outbreak successfully. With the onset of vaccination on 13 January 2021, we augment the model with the vaccination class to investigate the impact of vaccination rate and efficacy. We observe that vaccination rate is a more critical parameter than the vaccine efficacy to eliminate the disease successfully.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project is a mathematical model for the COVID-19 pandemic in Turkey and uses publicly available data, therefore is exempt from IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe have used data from TURCOVID19 project, which is presents publicly available data from Turkish Ministry of Health. The data can be found here: https://turcovid19.com/acikveri/ https://turcovid19.com/acikveri/